Comprehensive Cardiovascular Nursing: CAD, ACS, Heart Failure, and Aortic Aneurysms

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/153

flashcard set

Earn XP

Description and Tags

Comprehensive practice flashcards covering the pathophysiology, clinical manifestations, diagnostics, and interprofessional nursing management of coronary artery disease, acute coronary syndromes, heart failure, and aortic aneurysms.

154 Terms

1
New cards

Coronary Artery Disease (CAD)

A blood vessel disorder in the category of atherosclerosis characterized by lipid and fibrous plaque accumulation within coronary arteries, representing the leading cause of death in the United States.

2
New cards

Atherosclerosis

A disease process characterized by the progressive accumulation of lipid deposits, fibrous tissue, and calcium within arterial walls, leading to lumen narrowing and decreased tissue perfusion.

3
New cards

Chronic Endothelial Injury

The initial stage in the development of atherosclerosis caused by damage to the arterial endothelium from mechanical or biochemical insults, initiating an inflammatory vascular response.

4
New cards

Etiologies of Endothelial Injury

Precipitating insults that damage the vascular endothelium, including hypertension, tobacco use, hyperlipidemia, hyperhomocysteinemia, diabetes mellitus, infections, and circulating toxins.

5
New cards

Fatty Streak

The earliest macroscopic lesion of atherosclerosis, characterized by lipid accumulation that migrates into smooth muscle cells, creating a yellow appearance within the vessel wall.

6
New cards

Fatty Streak Clinical Presentation

An early vascular lesion typically present by age 2020 that is potentially reversible or slowed through aggressive lowering of low-density lipoproteins (LDL\text{LDL}).

7
New cards

Fibrous Plaque

A progressive atherosclerotic lesion where collagen covers the fatty streak, producing a greyish-white narrowing of the vessel lumen that reduces downstream blood flow and can develop fissures.

8
New cards

Fibrous Plaque Appearance and Timeline

A collagen-encapsulated atherosclerotic lesion that typically appears within coronary vessels by age 3030 and presents macroscopically with a greyish-white color.

9
New cards

Complicated Lesion

A critical, dangerous stage of atherosclerosis characterized by plaque rupture, thrombus formation, and significant lumen narrowing or total vessel occlusion, severely compromising oxygen perfusion.

10
New cards
<p>Stages of Atherosclerosis</p>

Stages of Atherosclerosis

The progressive four-stage pathophysiologic sequence comprising chronic endothelial injury, fatty streak development, fibrous plaque formation, and the unstable complicated lesion.

11
New cards
<p>Collateral Circulation</p>

Collateral Circulation

The arterial network of new channels developed by the body to bypass chronic, partial coronary artery blockages and maintain distal myocardial perfusion.

12
New cards

Modifiable Risk Factors for CAD

Controllable factors that accelerate atherosclerosis, including hypertension, tobacco use, elevated low-density lipoprotein levels, obesity, and unmanaged diabetes.

13
New cards

Non-Modifiable Risk Factors for CAD

Inherent individual risk characteristics for coronary artery disease that cannot be altered, including advanced age, male gender, and family history or genetic predisposition.

14
New cards

Hyperlipidemia in CAD

Elevated circulating serum lipids, particularly high levels of low-density lipoproteins (LDL\text{LDL}), that infiltrate injured endothelium and form vascular plaques.

15
New cards

Hyperhomocysteinemia

An elevated level of homocysteine in the blood that contributes directly to chronic vascular endothelial injury and accelerates atherosclerosis.

16
New cards

Tobacco Use in CAD Pathophysiology

A major modifiable risk factor that causes direct chemical endothelial injury, increases sympathetic tone, and promotes coronary platelet aggregation.

17
New cards

Hypertension in CAD Pathophysiology

Sustained high vascular hydrostatic pressure that causes chronic mechanical shear stress and endothelial injury, predisposing arteries to lipid infiltration.

18
New cards

Diabetes Mellitus in CAD Pathophysiology

A metabolic disorder that accelerates atherosclerosis by inducing endothelial injury, hyperlipidemia, and altered platelet function.

19
New cards

Chronic Stable Angina

Intermittent chest discomfort characterized by predictable onset, a duration of 5–15 minutes5\text{--}15\text{ minutes}, and relief following rest or the administration of sublingual nitroglycerin.

20
New cards

Precipitating Factors of Angina

Triggers that increase myocardial oxygen demand above available supply, including physical exertion, temperature extremes, strong emotions, consumption of heavy meals, and tobacco use.

21
New cards

Sublingual Nitroglycerin Protocol

The acute dosing guideline directing patients to take one sublingual tablet every 5 minutes5\text{ minutes} for up to 33 doses; if pain persists unresolved, emergency medical services (911911) must be called immediately.

22
New cards

Phosphodiesterase Inhibitor Contraindication

The strict avoidance of concurrent administration of nitroglycerin with phosphodiesterase-5 inhibitors like sildenafil due to the risk of profound, life-threatening hypotension.

23
New cards

Angina at Rest

Unpredictable chest discomfort occurring without physical exertion or provocation, indicating an unstable coronary condition that requires urgent hospital evaluation.

24
New cards

Therapeutic Lifestyle Changes for CAD

Non-pharmacologic primary and secondary interventions including dietary modifications (low saturated fat, low cholesterol), regular physical activity, weight management, and complete tobacco cessation.

25
New cards

Acute Coronary Syndrome (ACS)

An umbrella medical term encompassing an urgent spectrum of myocardial ischemia including unstable angina, Non-ST-Segment-Elevation Myocardial Infarction, and ST-Segment-Elevation Myocardial Infarction.

26
New cards
<p>Acute Coronary Syndrome Continuum</p>

Acute Coronary Syndrome Continuum

The clinical progression where worsening coronary atherosclerosis destabilizes from chronic stable angina into unstable angina, NSTEMI, or STEMI.

27
New cards

Myocardial Ischemia

A condition characterized by insufficient arterial blood flow and oxygen delivery to cardiac myocytes that is typically reversible upon timely reperfusion.

28
New cards

Myocardial Infarction (MI)

Irreversible necrosis and death of myocardial tissue resulting from prolonged, severe deprivation of oxygen and arterial blood supply.

29
New cards

Timeframe of Myocardial Hypoxia

The rapid cellular physiological event where cardiac muscle becomes severely hypoxic within 10 seconds10\text{ seconds} of total coronary artery occlusion.

30
New cards

Anaerobic Metabolism in Ischemia

The compensatory, oxygen-deprived metabolic pathway activated during acute coronary occlusion that leads to lactic acid accumulation and metabolic acidosis.

31
New cards

Myocardial Cell Viability Limit

The critical time threshold of approximately 20 minutes20\text{ minutes} during total ischemia after which irreversible myocardial cell death occurs if blood flow is not restored.

32
New cards

Reperfusion Restoration Window

The prompt therapeutic restoration of coronary blood flow within 20 minutes20\text{ minutes} that restores aerobic metabolism, re-establishes contractility, and rescues ischemic myocytes.

33
New cards

Plaque Deterioration Mechanism

The acute event wherein a previously stable atheromatous plaque ruptures, exposing thrombogenic core lipids to platelets and initiating thrombus aggregation.

34
New cards

Unstable Angina (UA)

Chest discomfort caused by partial coronary occlusion that occurs at rest, exhibits a new onset or crescendo pattern, and is not associated with elevated serum cardiac biomarkers.

35
New cards

Non-ST-Segment-Elevation Myocardial Infarction (NSTEMI)

Myocardial necrosis caused by partial coronary occlusion characterized by elevated serum cardiac biomarkers without acute ST-segment elevation on a 12-lead ECG.

36
New cards

ST-Segment-Elevation Myocardial Infarction (STEMI)

Severe transmural myocardial necrosis resulting from complete, total coronary artery occlusion that produces classic ST-segment elevation across affected ECG leads and biomarker elevations.

37
New cards
<p>Left Anterior Descending (LAD) Coronary Artery Occlusion</p>

Left Anterior Descending (LAD) Coronary Artery Occlusion

An occlusion of the anterior descending coronary artery that causes anterior wall myocardial infarction, frequently compromising left ventricular ejection.

38
New cards

Circumflex Coronary Artery

A major branch of the left coronary artery supplying the lateral and posterior walls of the left ventricle and portions of the cardiac conduction system.

39
New cards

Right Coronary Artery (RCA)

The coronary artery supplying the right atrium, right ventricle, inferior left ventricular wall, and the sinoatrial and atrioventricular nodes.

40
New cards

Classic Pain Manifestations of MI

Severe, immobilizing chest pressure, heaviness, tightness, or burning that persists unrelieved by rest or nitroglycerin and commonly radiates to the neck, jaw, arms, or back.

41
New cards

Atypical MI Presentation

Subtle, non-classic manifestations of myocardial infarction commonly seen in women, older adults, and individuals with diabetes, presenting as epigastric discomfort, dyspnea, nausea, or profound fatigue.

42
New cards

Sympathetic Nervous System Stimulation in MI

The acute neurohormonal reflex response to severe ischemic pain that triggers catecholamine release, resulting in diaphoresis, peripheral vasoconstriction, cool/clammy skin, and transient tachycardia.

43
New cards

Gastrointestinal Symptoms of MI

Nausea and vomiting resulting from vasovagal reflexes or reflex stimulation of the medullary vomiting center secondary to severe cardiac ischemic pain.

44
New cards

Fever Manifestation in MI

A low-grade systemic temperature elevation that develops within 24 to 48 hours24\text{ to }48\text{ hours} following acute myocardial infarction secondary to widespread myocardial necrosis and inflammatory cytokine release.

45
New cards

Ventricular Gallops (S3 and S4)

Abnormal heart sounds heard on cardiac auscultation post-MI reflecting left ventricular compliance defects, elevated filling pressures, or acute ventricular dysfunction.

46
New cards

Dysrhythmias Complication of MI

The most frequent acute complication following acute myocardial infarction, caused by electrical instability, ischemic injury to conduction pathways, and altered electrolyte exchange.

47
New cards

Ventricular Fibrillation (V-Fib)

A chaotic, lethal ventricular rhythm frequently triggered during acute myocardial infarction that causes total cessation of effective cardiac output and requires immediate defibrillation.

48
New cards

Cardiogenic Shock

A severe state of end-organ hypoperfusion occurring when extensive left ventricular infarction leaves the myocardium unable to generate adequate cardiac output to sustain vital functions.

49
New cards

Papillary Muscle Dysfunction

Ischemic injury to papillary structures causing new-onset mitral valve regurgitation, audible as an apical systolic murmur and causing rapid pulmonary congestion.

50
New cards

Papillary Muscle Rupture

A catastrophic mechanical tear of the infarcted papillary muscle producing massive acute mitral regurgitation, acute pulmonary edema, and sudden cardiogenic collapse.

51
New cards

Ventricular Septal Wall Rupture

A mechanical rupture within the interventricular septum post-MI that produces a harsh holosystolic murmur, a left-to-right shunt, and rapid hemodynamic decompensation.

52
New cards

Left Ventricular Aneurysm

A structural complication where the thinned, infarcted ventricular wall bulges outward during systole, harboring thrombi, inducing dysrhythmias, and worsening heart failure.

53
New cards

Acute Pericarditis Post-MI

Inflammation of the pericardial sac occurring 2 to 3 days2\text{ to }3\text{ days} post-infarction, characterized by pleuritic chest pain relieved by sitting forward, generalized ST elevation, and a friction rub.

54
New cards

Dressler Syndrome

An autoimmune-mediated pericarditis accompanied by fever and joint pain that develops 1 to 8 weeks1\text{ to }8\text{ weeks} after myocardial infarction.

55
New cards

Medical Management of Dressler Syndrome

The administration of high-dose aspirin as the initial treatment of choice to suppress autoimmune pericardial inflammation and alleviate arthralgia.

56
New cards

Acute Inflammatory Phase of MI Healing

The cellular response within the initial 24 hours24\text{ hours} post-MI where neutrophils and monocytes infiltrate the necrotic zone to degrade and clear dead myocardial tissue.

57
New cards

Proteolytic Enzymes in Myocardial Repair

Digestive enzymes released by infiltrating neutrophils and macrophages that clear necrotic cellular debris while temporarily thinning the myocardial wall.

58
New cards

Myocardial Vulnerability Window

The period between 10 and 14 days10\text{ and }14\text{ days} post-MI when developing scar tissue remains structurally weak, making the ventricular wall particularly vulnerable to physical stress.

59
New cards

Scar Tissue Replacement Timeline

The healing milestone achieved approximately 6 weeks6\text{ weeks} following myocardial infarction where permanent, non-contractile collagenous scar tissue completely replaces necrotic myocardium.

60
New cards

Ventricular Remodeling Post-MI

The compensatory structural alteration whereby non-infarcted myocardium dilates and hypertrophies in an attempt to maintain stroke volume, often ultimately predisposing to heart failure.

61
New cards
<p>Serum Cardiac Biomarkers Timeline</p>

Serum Cardiac Biomarkers Timeline

The characteristic diagnostic patterns of rise, peak, and clearance for cardiac troponin, CK-MB, and myoglobin following acute myocardial cell necrosis.

62
New cards

Cardiac-Specific Troponin (cTn)

The gold-standard biomarker of myocardial injury that begins rising within hours of infarction, peaks at 15 to 24 hours15\text{ to }24\text{ hours}, and remains detectable for 10 to 14 days10\text{ to }14\text{ days}.

63
New cards

Creatine Kinase-MB (CK-MB)

A cardiac isoenzyme biomarker that rises within 3 to 6 hours3\text{ to }6\text{ hours} after myocardial necrosis, reaches peak levels at 15 to 24 hours15\text{ to }24\text{ hours}, and returns to baseline within 2 to 3 days2\text{ to }3\text{ days}.

64
New cards

Myoglobin Biomarker

An early serum protein biomarker that rises within 1 to 4 hours1\text{ to }4\text{ hours} following cardiac injury and peaks around 4 hours4\text{ hours}, though it lacks cardiac tissue specificity.

65
New cards

ST-Segment Elevation on 12-Lead ECG

An electrocardiographic finding indicating acute, transmural myocardial injury and total coronary occlusion requiring immediate emergent reperfusion therapy.

66
New cards

ST-Segment Depression and T-Wave Inversion

Electrocardiographic indicators demonstrating subendocardial myocardial ischemia or Non-ST-Segment-Elevation Myocardial Infarction.

67
New cards

Emergent Percutaneous Coronary Intervention (PCI)

The primary catheter-based invasive reperfusion strategy used to rapidly recanalize an occluded coronary vessel in patients presenting with STEMI.

68
New cards
<p>Door-to-Balloon Benchmark for STEMI</p>

Door-to-Balloon Benchmark for STEMI

The strict quality-of-care standard requiring patients presenting with confirmed STEMI to undergo coronary balloon inflation within 90 minutes90\text{ minutes} of hospital arrival.

69
New cards

Bare-Metal Stents vs. Drug-Eluting Stents

Intracoronary endovascular scaffolds deployed during PCI, where drug-eluting models are coated with antiproliferative agents to prevent in-stent restenosis.

70
New cards

Door-to-Needle Benchmark

The performance standard requiring intravenous administration of thrombolytic therapy within 30 minutes30\text{ minutes} of hospital arrival when emergent PCI is unavailable.

71
New cards

Coronary Artery Bypass Graft (CABG) Surgery

Surgical revascularization wherein conduits (such as saphenous veins or internal mammary arteries) are grafted to bypass multi-vessel or severe left main coronary disease.

72
New cards

Dual Antiplatelet Therapy (DAPT)

The combined pharmacologic regimen of aspirin along with a P2Y12 platelet receptor inhibitor (such as clopidogrel) prescribed to prevent coronary stent thrombosis.

73
New cards

Glycoprotein IIb/IIIa Inhibitors

Potent intravenous antiplatelet agents administered in unstable angina or NSTEMI to prevent final-pathway fibrinogen binding and platelet aggregation.

74
New cards

Intravenous Nitroglycerin in ACS

A continuous vasodilator infusion used in acute coronary syndrome to reduce cardiac preload, decrease myocardial wall tension, and relieve persistent ischemic chest pain.

75
New cards

Morphine Sulfate in ACS

An intravenous opioid administered for refractory chest pain that relieves severe discomfort, reduces preload and afterload through vasodilation, and decreases anxiety.

76
New cards

Beta-Adrenergic Blockers in ACS

Pharmacotherapy administered to decrease heart rate, reduce systemic blood pressure, attenuate myocardial contractility, and lower myocardial oxygen demand post-MI.

77
New cards

High-Dose Statin Therapy Post-ACS

The immediate administration of aggressive lipid-lowering medication (such as atorvastatin) to stabilize plaques and reduce future vascular events following an acute coronary event.

78
New cards

Nutritional Therapy for ACS

The dietary progression starting with NPO status during acute presentation, advancing to a diet low in sodium, saturated fat, and cholesterol.

79
New cards

Heart Failure (HF)

A clinical syndrome characterized by the inability of the heart to pump sufficient blood to meet the metabolic and oxygen demands of tissues and organs.

80
New cards

Leading Demographic for HF Admissions

Older adults over the age of 6565, for whom heart failure represents the most common reason for inpatient hospital admission.

81
New cards

Primary Etiologies of Heart Failure

The two most prevalent underlying clinical causes of myocardial insult and subsequent heart failure: hypertension and coronary artery disease.

82
New cards

Cardiac Output (CO)

The volume of blood ejected by the heart per minute, serving as a primary indicator of systemic tissue perfusion.

83
New cards

Cardiac Output Mathematical Formula

The physiological equation defining cardiac output as the product of stroke volume and heart rate: CO=SV×HRCO = SV \times HR.

84
New cards

Normal Adult Cardiac Output Range

The typical physiologic resting cardiac output volume in a healthy adult, measuring between 4 and 8 L/min4\text{ and }8\text{ L/min}.

85
New cards

Stroke Volume (SV)

The absolute volume of blood pumped out of the ventricle with each individual heartbeat.

86
New cards

Determinants of Stroke Volume

The three fundamental physiological properties that regulate stroke volume: preload, afterload, and myocardial contractility.

87
New cards

Preload

The volume of blood in the ventricles at the end of diastole, representing the initial stretch applied to myocardial muscle fibers prior to contraction.

88
New cards

Afterload

The resistance or systemic arterial pressure against which the left ventricle must pump to eject blood into circulation during systole.

89
New cards

Myocardial Contractility

The inherent force and velocity of myocardial fiber shortening independent of changes in preload or afterload.

90
New cards

Ejection Fraction (EF)

The percentage of total left ventricular end-diastolic blood volume ejected from the ventricle during each subsequent systolic contraction.

91
New cards

Normal Left Ventricular Ejection Fraction (LVEF)

The physiological normal range for resting left ventricular ejection fraction, established between 55% and 65%55\text{\% and }65\text{\%}.

92
New cards

Heart Failure with Reduced Ejection Fraction (HFrEF)

A form of systolic heart failure characterized by impaired ventricular contractility and an ejection fraction generally below 40%40\%.

93
New cards

Pathophysiology of HFrEF

A failure of the left ventricle to generate adequate systolic pressure to eject blood forward, causing blood to pool in the left atrium and back up into pulmonary vasculature.

94
New cards

Heart Failure with Preserved Ejection Fraction (HFpEF)

A form of diastolic heart failure wherein the left ventricle is stiff and noncompliant, impairing diastolic filling despite a normal ejection fraction (≥50%\ge 50\%).

95
New cards

Diagnostic Criteria for HFpEF

The clinical diagnosis confirmed by clinical signs and symptoms of heart failure, normal LVEF on echocardiogram, and evidence of diastolic filling dysfunction.

96
New cards

Left-Sided Heart Failure

The most common form of heart failure, characterized by left ventricular dysfunction, retrograde blood pooling into pulmonary veins, and elevated pulmonary hydrostatic pressure.

97
New cards

Pulmonary Hydrostatic Pressure Elevation

The hemodynamic consequence of left ventricular failure where blood backing up from the left atrium forces fluid out of pulmonary capillaries into lung parenchyma.

98
New cards

Respiratory Manifestations of Left HF

Clinical pulmonary signs resulting from fluid backup into lungs, including dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, crackles, and tachypnea.

99
New cards

Right-Sided Heart Failure

Ventricular dysfunction characterized by the inability of the right ventricle to pump blood forward into pulmonary circulation, causing fluid backup into the systemic venous system.

100
New cards

Primary Etiology of Right-Sided HF

Left-sided heart failure, which causes chronic backward pulmonary venous congestion and secondary pulmonary hypertension that overworks the right ventricle.